IRIS
DRAGONI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.418
NA - Nord America 1.093
AS - Asia 164
SA - Sud America 11
AF - Africa 4
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.695
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.088
IE - Irlanda 381
IT - Italia 313
GB - Regno Unito 310
SE - Svezia 140
FR - Francia 92
CN - Cina 61
DE - Germania 47
RU - Federazione Russa 34
SG - Singapore 29
FI - Finlandia 28
ES - Italia 21
IN - India 19
UA - Ucraina 19
VN - Vietnam 17
BE - Belgio 11
PK - Pakistan 11
BR - Brasile 10
GR - Grecia 6
IR - Iran 6
CA - Canada 5
CZ - Repubblica Ceca 4
HK - Hong Kong 3
KR - Corea 3
NG - Nigeria 3
NP - Nepal 3
PL - Polonia 3
TR - Turchia 3
AU - Australia 2
JP - Giappone 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
MY - Malesia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.695
Salva come PNG Salva come JPEG
Città #
Dublin 377
Southend 292
Chandler 224
Fairfield 146
Siena 96
Ashburn 69
Seattle 58
Princeton 50
Woodbridge 50
Cambridge 48
Houston 45
New York 45
Wilmington 38
Ann Arbor 28
Helsinki 28
Rome 23
Beijing 21
Málaga 19
Shanghai 18
Dong Ket 17
Boardman 16
San Diego 16
Jacksonville 15
Singapore 15
Brussels 11
Dallas 11
San Mateo 11
Florence 10
Dearborn 9
Fremont 9
Islamabad 8
Milan 8
Moscow 8
Brescia 7
Divinópolis 7
London 7
Roccagorga 7
Jaipur 6
Paris 6
Redwood City 5
Andover 4
Brno 4
Cagliari 4
Ithaca 4
Leawood 4
Naples 4
San Francisco 4
Bucheon-si 3
Carmignano 3
Guangzhou 3
Kathmandu 3
Lagos 3
Mumbai 3
Munich 3
Ouro Branco 3
Padova 3
Perugia 3
Taranto 3
Toronto 3
Zanjan 3
Agrigento 2
Auckland 2
Azzano San Paolo 2
Briey 2
Central 2
Chicago 2
Earlsfield 2
Esslingen am Neckar 2
Foggia 2
Frankfurt am Main 2
Glen Allen 2
Golders Green 2
Grosseto 2
Haikou 2
Hebei 2
Jinan 2
Karachi 2
Kashan 2
Nanjing 2
Orangeburg 2
Oslo 2
Palermo 2
Redmond 2
Reggio Emilia 2
Romainville 2
Saint-Fons 2
Scandicci 2
Segrate 2
Strigno 2
Sunderland 2
Turin 2
Verona 2
Washington 2
Accra 1
Acton 1
Adana 1
Alcorcón 1
Almaty 1
Antea 1
Arezzo 1
Totale 2.024
Salva come PNG Salva come JPEG
Nome #
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 211
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 196
Antiviral drug development for treatment of acute and chronic viral infections 193
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 162
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 146
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 141
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 124
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 119
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 118
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 107
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy 105
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 87
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 84
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic 80
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 70
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 65
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 58
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 57
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 55
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 54
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 52
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection 52
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 49
Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm 48
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 46
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 43
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 40
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 37
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 35
null 32
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 31
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies 27
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 18
SARS-CoV2 infection in human testis and sperm: in vivo and in vitro studies 14
null 14
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 12
null 12
Totale 2.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020290 0 12 67 25 19 25 31 22 22 35 14 18
2020/2021385 11 17 6 27 34 43 37 52 34 49 28 47
2021/2022645 33 61 49 72 44 43 45 42 41 46 61 108
2022/2023713 43 104 81 62 59 130 40 51 44 35 34 30
2023/2024653 20 22 59 39 12 179 215 18 0 14 31 44
2024/202570 36 34 0 0 0 0 0 0 0 0 0 0
Totale 2.794